Thanks to ObamaCare, you can now see how much money your doctor gets from drugmakers


Earlier this week, with little fanfare, the Department of Health and Human Services (HHS) released a public database of information about how much money and in-kind benefits doctors have been receiving from pharmaceutical and medical device makers. Only gifts of $10 or more are counted.
The Open Payments database — a requirement of the 2010 Affordable Care Act, or ObamaCare — is incomplete, with data from only the last five months of 2013 so far. But the numbers aren't small: From August to December, 546,000 Doctors, dentists, podiatrists, optometrists, and chiropractors plus 1,360 teaching hospitals received more than $3.48 billion in cash, gifts and in-kind services, stock options, and research grants from drugmakers and device makers. HHS is still verifying 300,000 records it didn't include in the database, so the total amount will rise. The biggest spenders so far are Genetech, Pfizer, and DePuy Synthes.
The idea is that, once the database is fully functional, patients and other interested parties will be able to see a doctor's financial ties to companies, so they can evaluate a doctor's treatments and — more importantly — to discourage conflicts of interest. The American Medical Association opposes the database, arguing that the numbers are out of context and potentially misleading, but this part of ObamaCare has bipartisan support.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
After a day or so of digging through the numbers, The New York Times has some of the biggest recipients — the typical doctor received $1,750 in those five months, but at least 130 named doctors pulled in more than $100,000 — and some of the largest potential conflicts of interest. If you're interested in a broader look at where the pharmaceutical/device money comes from and goes to, ProPublica has been tracking the cash for four years.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Settling the West Bank: a death knell for a Palestine state?
In the Spotlight The reality on the ground is that the annexation of the West Bank is all but a done deal
-
Sudoku medium: August 23, 2025
The Week's daily medium sudoku puzzle
-
Sudoku hard: August 23, 2025
The Week's daily hard sudoku puzzle
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC